Guizhou Xinbang Pharmaceutical Co., Ltd.
SZSE:002390.SZ
4.56 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||||
| Net Income
| 155.69 | 287.233 | 268.416 | 373.955 | 220.575 | 263.722 | -1,283.183 | 331.486 | 242.704 | 168.409 | 153.857 | 39.676 | 47.563 | 45.877 | 37.582 | 46.416 | 33.614 | 29.911 | 17.451 |
| Depreciation & Amortization
| 218.096 | 236.71 | 243.546 | 247.33 | 231.647 | 238.385 | 214.88 | 174.601 | 150.039 | 126.655 | 50.099 | 19.743 | 7.554 | 6.797 | 7.425 | 7.613 | 7.579 | 6.915 | 0 |
| Deferred Income Tax
| 0 | -11.043 | -6.785 | -9.109 | 6.413 | -9.584 | -7.816 | -8.56 | -14.294 | -2.793 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 31.478 | 6.002 | -6.413 | 9.584 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 153.599 | 94.059 | -117.134 | -338.615 | 74.841 | 151.692 | -897.541 | -435.074 | -802.649 | -217.231 | -483.46 | -98.543 | -104.933 | -102.666 | -46.513 | -21.775 | -25.462 | -13.902 | 0 |
| Accounts Receivables
| 334.131 | 103.289 | 94.98 | -609.768 | 348.147 | 198.382 | -647.041 | -356.118 | -450.094 | -573.134 | -709.603 | 10.38 | -69.873 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -63.636 | 24.415 | -97.01 | -92.314 | 150.922 | 50.141 | -344.425 | 44.4 | -90.111 | -70.264 | -79.824 | -150.84 | -29.944 | -70.615 | -5.562 | -11.904 | -27.639 | -0.611 | 0 |
| Accounts Payables
| 0 | -33.646 | -108.319 | 372.576 | -430.64 | -87.247 | 101.74 | -114.796 | -248.15 | 428.96 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -116.895 | 0 | -6.785 | -9.109 | 6.413 | -9.584 | -553.116 | -479.475 | -712.539 | -146.967 | -403.636 | 52.297 | -74.99 | -32.051 | -40.951 | -9.871 | 2.176 | -13.292 | 0 |
| Other Non Cash Items
| 107.583 | 183.659 | 171.275 | 178.408 | 215.049 | 232.529 | 1,747.282 | 130.73 | 211.321 | 139.568 | 80.907 | 17.786 | 13.352 | 10.125 | 4.007 | 9.499 | 9.13 | 9.562 | -17.451 |
| Operating Cash Flow
| 634.969 | 790.618 | 590.797 | 457.972 | 742.112 | 886.328 | -218.563 | 201.743 | -198.585 | 217.402 | -198.597 | -21.338 | -36.464 | -39.867 | 2.501 | 41.753 | 24.861 | 32.486 | 0 |
| Investing Activities: | |||||||||||||||||||
| Investments In Property Plant And Equipment
| -124.868 | -135.781 | -158.781 | -253.765 | -138.087 | -207.536 | -263.519 | -435.029 | -432.231 | -492.478 | -282.637 | -44.801 | -52.764 | -96.481 | -74.617 | -6.647 | -6.971 | -28.949 | -39.267 |
| Acquisitions Net
| 0 | 36.555 | 1.608 | -295.489 | 566.096 | 7.129 | -39.124 | -0.213 | 61.52 | 43.711 | 50.369 | -34.345 | -55.892 | 0 | 0 | 3.536 | 0 | 0 | 39.267 |
| Purchases Of Investments
| 0 | -0.3 | -12.4 | -1,719.6 | -1,516.47 | -60 | -0 | -439.762 | -663.978 | -211.107 | -371.934 | -426.5 | -90 | -6.05 | -4 | 0 | 0 | 0 | -3.42 |
| Sales Maturities Of Investments
| 7.183 | 14.803 | 51.001 | 1,523.636 | 1,494.739 | 1.555 | 86.118 | 433.736 | 426.58 | 206.786 | 285.518 | 368.701 | 70.565 | 0 | 0 | 0 | 0 | 0 | 0.28 |
| Other Investing Activites
| 2.653 | 134.983 | 0.55 | 0.874 | 1.719 | 5.533 | 0.231 | 1.103 | 7.844 | 1.22 | -54.439 | 0.047 | 0.003 | -96.481 | -74.617 | -0.05 | 5.002 | 6.618 | -39.267 |
| Investing Cash Flow
| -115.031 | 50.259 | -118.021 | -744.344 | 407.997 | -253.318 | -216.294 | -440.164 | -600.266 | -451.867 | -373.123 | -136.898 | -128.088 | -102.531 | -78.617 | -3.16 | -1.969 | -22.33 | -42.407 |
| Financing Activities: | |||||||||||||||||||
| Debt Repayment
| -5 | -606.19 | -34.1 | -2,144.97 | -327.86 | -440.83 | 437.33 | 898.407 | 328.793 | 325 | 722.198 | 0 | 32.75 | 60 | -17 | -20 | 18 | -24 | 52 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 86.188 | 369.192 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -141.401 | 0 | 0 | -86.188 | -369.192 | -300 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -192.29 | -116.631 | -116.631 | -230.337 | -197.563 | -206.95 | -252.545 | -185.875 | -179.596 | -154.733 | -89.119 | -26.249 | -21.392 | -33.492 | -3.474 | -6.362 | -9.641 | -8.718 | -11.002 |
| Other Financing Activities
| -120.616 | -43.958 | 13.033 | 1,464.737 | 24.453 | 34.203 | 18.244 | -29.561 | -152.522 | -123.851 | 294.011 | 78.773 | -0 | 33.492 | 642.436 | 0 | -0 | 0 | -0 |
| Financing Cash Flow
| -317.907 | -908.18 | -189.424 | -910.57 | -587.158 | -982.769 | -96.97 | 682.971 | 1,822.853 | 171.718 | 927.091 | 52.524 | 11.358 | 26.508 | 621.962 | -26.362 | 8.359 | -32.718 | 40.998 |
| Other Information: | |||||||||||||||||||
| Effect Of Forex Changes On Cash
| -0.001 | 0.002 | 0.001 | -0.001 | 2.263 | 0.285 | 12.693 | -10.042 | 8.459 | 0 | -0 | -0 | 0 | 0 | 0 | -0 | 0.019 | 0 | 0 |
| Net Change In Cash
| 202.03 | -66.321 | 283.352 | -1,196.944 | 565.214 | -349.474 | -519.135 | 434.508 | 1,032.461 | -62.747 | 355.371 | -105.712 | -153.195 | -115.889 | 545.846 | 12.23 | 31.27 | -22.562 | 5.937 |
| Cash At End Of Period
| 932.72 | 730.69 | 797.011 | 513.659 | 1,710.602 | 1,145.388 | 1,494.862 | 2,013.997 | 1,579.489 | 547.028 | 609.775 | 254.404 | 360.116 | 513.311 | 629.2 | 83.355 | 71.124 | 39.854 | 62.416 |